Dudediligence.

Mineralys Therapeutics, Inc

MLYSNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$56.3MSep ’24−$48.9MDec ’24−$42.2MMar ’25−$43.3MJun ’25−$36.9MSep ’25−$32.2MDec ’25−$39.3MMar ’26−$241.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on file−$31.5M−$84.7M−$192.4M−$170.6M
Net incomenone on file−$29.8M−$71.9M−$177.8M−$154.7M
Operating cash flownone on file−$29.2M−$81.2M−$166.3M−$142.4M
Free cash flownone on filenone on file−$81.2M−$166.4M−$142.4M
Cash$10.7M$87.7M$49.3M$114.1M$172.9M
Shares outstandingnone on file6.4M41.1M49.8M81.5M